Breakthrough Therapy

Psychedelic industry faced setbacks, cannabis was almost rescheduled and overdose deaths dropped

AstraZeneca has voluntarily withdrawn its marketing authorisation application with the EU's medicines regulator for its experimental precision drug for the treatment of a...

/PRNewswire-PRWeb/ -- The Clinical Leukemia Service at Roswell Park Comprehensive Cancer Center helped lead the first clinical trial of the experimental oral...

After the FDA rejected its proposed MDMA treatment, Lykos Therapeutics is laying off 75 percent of its staff and its founder has left the company.

The US Food and Drug Administration has declined to approve MDMA-assisted therapy for the treatment of PTSD.

Advocates are still fighting to get the psychedelic drug approved as a mental health treatment, despite its rejection by the FDA's advisory committee in June. They face an uphill battle.

News and commentary from the psychiatry world

Psychotropic drugs are all the rage now as a potential treatment of brain diseases, for example, ketamine and psilocybin for depression and PTSD. More recently, a single dose of LSD was found to have a long-lasting effect on generalized anxiety disorder. Some simple chemistry may explain how LSD can persist in the brain long after it is gone from the blood.

A court victory on rescheduling psilocybin leads the plaintiffs to believe that a separate pending case could allow the drug's use under right-to-try laws.

Edwards Lifesciences received approval for its Evoque tricuspid valve replacement system, the first transcatheter therapy approved in the US for tricuspid regurgitation.

Cody Shandraw of Ambria Capital believes the regulator could allow the drug to treat PTSD as soon as August

Benefits demonstrated in major depression, bipolar depression, PTSD, and anorexia

There is growing interest in Congress for approval of psychedelics as a treatment for those afflicted with PTSD and depression

From bioprinted pancreatic tissue to AI-backed mental health treatment plans, these technologies are changing the game in the world of health.

A Parkinson's patient can now walk without falling frequently due to an implant targeting the spinal cord.

Researchers believe psilocybin changes the way the brain organizes itself, helping a user adopt new attitudes and overcome mental health issues.

Proponents hope Oregon's legalization will spark a revolution in mental health care.

Elranatamab is an off-the-shelf, B-cell maturation antigen CD3-targeted bispecific antibody.

Australia is now the first country to allow psychiatrists to prescribe certain psychedelic substances to patients with depression or post-traumatic stress disorder. Australian physicians can now prescribe doses of MDMA, also known as ecstasy, for PTSD. Psilocybin, the psychoactive ingredient in psychedelic mushrooms, can be given to people who have hard-to-treat depression. Medical experts in the U.S. and elsewhere…

Thousands are in Denver this week to learn about the future of psychedelics like magic mushrooms and MDMA, and to talk business.